MARKET WIRE NEWS
  1. Home
  2. Stock
  3. PRAX
  4. News
PRAX
Quote
Short
News
Articles
Message Board

Praxis Precision Medicines Inc. (NASDAQ : PRAX ) News

News Releases

PRAX News Releases
PRAX : NASDAQ
SeekingAlpha
10 mid-cap U.S. healthcare stocks with the strongest momentum grades
PRAX : NASDAQ
SeekingAlpha
Praxis 'Strong Buy': PDUFA In Early 2027 For Ulixacaltamide And BTD Elsunersen
PRAX : NASDAQ
SeekingAlpha
10 mid-cap U.S. stocks with the strongest momentum grades
PRAX : NASDAQ
SeekingAlpha
Praxis gains FDA Breakthrough Therapy Status for elsunersen for encephalopathy
PRAX : NASDAQ
SeekingAlpha
As AbbVie eyes Apogee, these biotech stocks earn the highest Quant ratings
PRAX : NASDAQ
GlobeNewswire
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of Function Variants
PRAX : NASDAQ
SeekingAlpha
Praxis a new outperform at RBC on recent pullback
PRAX : NASDAQ
KlickAnalytics
PRAX Price Target Alert: $449.00. Issued by RBC Capital
PRAX : NASDAQ
SeekingAlpha
Praxis Precision Medicines, Inc. (PRAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
PRAX : NASDAQ
SeekingAlpha
Praxis' Premium Price May Reflect Unrealistic Market Prospects In Essential Tremor
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.